Press Coverage

NEW YORK, NY, TAMPA, FL and BATON ROUGE, LA – November 17, 2020 – Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced the completion of clinical validation and CLIA certification for MOTO+PARA’s mobile lab. The Company’s mobile CLIA lab partner, Integrated Health LLC, has fully validated the clinical performance of the proprietary COVID-19 RT-PCR laboratory testing process performed in MOTO+PARA’s Mobile High Complexity Labs built to biosafety level 3 (BSL3) and has received the approval needed to begin offering COVID-19 screening and analysis as a service to clients anywhere in the United States.

Rapid antigen and antibody testing also have been validated and are now ready to be deployed. MOTO+PARA is prepared to accept contracts from prospective clients immediately.

Click to read the full press release

NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE – October 23, 2020 – Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced the completion of the instrument validation in its mobile lab division. The Company’s mobile CLIA lab partner, Integrated Health, has fully validated the analytical performance of the Company’s proprietary ANDis 350 RNA auto-extraction machine in combination with its Accurate 96 qPCR machine as part of the COVID-19 RT-PCR laboratory testing validation process being performed in MOTO+PARA’s Mobile High Complexity Lab. Integrated Health expects to complete the clinical validation needed to support the commercial launch in mid-November. MOTO+PARA is in talks with several entities and expects to begin accepting contracts in mid-November 2020.

Click to read the full press release

NEW YORK, NY, TAMPA FL, BATON ROUGE, LA (October 7, 2020) – Todos Medical Ltd. (OTCQB:
TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into an exclusive supply agreement with U.S. national mobile CLIA laboratory company Integrated Health LLC operating MOTOPARA Foundation’s mobile biosafety level 3-built laboratories (the “Mobile Labs”) developed to address the global COVID-19 pandemic.

Click to read the full press release